National Bank of Canada’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$4.22K	Buy	+116	New	+$4.22K	﹤0.01%	2160
2023 Q3	–	Sell	-4,063	Closed	-$190K	–	2621
2023 Q2	$190K	Sell	4,063 -1,150	-22%	-$53.7K	﹤0.01%	1333
2023 Q1	$211K	Buy	+5,213	New	+$211K	﹤0.01%	1281